Slow‐release vaginal insert of misoprostol versus orally administrated solution of misoprostol for the induction of labour in primiparous term pregnant women: a randomised controlled trial

Objective To compare the World Health Organization (WHO) recommended orally administrated dosage of misoprostol (25 μg) with a vaginal slow‐release (7 μg/hour) insert of misoprostol regarding time from induction to delivery and safety of the method. Design Open label, Randomised controlled trial (RC...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BJOG : an international journal of obstetrics and gynaecology 2019-08, Vol.126 (9), p.1148-1155
Hauptverfasser:	Wallström, T, Strandberg, M, Gemzell‐Danielsson, K, Pilo, C, Jarnbert‐Pettersson, H, Friman‐Mathiasson, M, Wiberg‐Itzel, E
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravaginal Administration, Oral Adult Apgar Score Caesarean section Cardiotocography - statistics & numerical data Childbirth & labor Delayed-Action Preparations Delivery, Obstetric - statistics & numerical data Evidence-based medicine Female Fetuses Folkhälsovetenskap, global hälsa och socialmedicin Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi Gestation Hemorrhage Humans Hälsovetenskap Induced labor induction of labour Infant, Newborn Klinisk medicin Labor, Induced - methods Medicin och hälsovetenskap Misoprostol Misoprostol - administration & dosage Neonates Oral administration oral solution of misoprostol Oxytocics - administration & dosage Parity Postpartum Pregnancy Reproduktionsmedicin och gynekologi slow‐release vaginal insert of misoprostol Sweden Terbutaline Term Birth - drug effects Time Factors Treatment Outcome Vagina VD24 Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!